Layton Crouch is listed as a director on 2 SEC Form D filings by 1 issuer between Nov 2009 and May 2011: Proton Therapy USA, Inc. (Bozeman, MT — other health care — 2009–2011; $3.01M reported sold to 35 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jerry Pogue (2 shared filings), Ronald Anderson (2 shared filings), Joseph Leonard (1 shared filing) and Vernon Loucks (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Layton. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Layton Crouch and found 10 differences: Joseph Leonard is both a listed promoter and a paid seller; Layton Crouch appears on 1 deal that stopped filing before reaching its target; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.